F. Gu

Molecular Biology · Proceedings of the National Academy of Sciences of the United States of America · 2008

A researcher in the Science corpus: 5 papers; trusts 3 researchers and is trusted by 1 researcher here, as inferred from the citation graph.

Subfields

Whom F. Gu trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. O. Farokhzad
  2. Vladimir Torchilin
  3. Mauro Ferrari

Who trusts F. Gu overall

  1. Liangfang Zhang
  2. O. Farokhzad
  3. Juliana M. Chan
  4. J. S. Suk
  5. T. Gokmen
  6. Stephanie D. Steichen
  7. N. Bertrand
  8. N. Kamaly
  9. Amit Mittal
  10. S. Bhattacharyya

Papers from F. Gu's perspective

Ordered by how strongly the researchers F. Gu trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. (Proceedings of the National Academy of Sciences of the United States of America)
  2. Recent advances with liposomes as pharmaceutical carriers (Nature reviews. Drug discovery)
  3. Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery. (Journal of Controlled Release)
  4. Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer. (Cancer Research)
  5. Polymer conjugates as anticancer nanomedicines (Nature Reviews. Cancer)
  6. Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. (Progress in lipid research)
  7. Phase I and Pharmacokinetic Study of Genexol-PM, a Cremophor-Free, Polymeric Micelle-Formulated Paclitaxel, in Patients with Advanced Malignancies (Clinical Cancer Research)
  8. Nanoscale coordination polymers for platinum-based anticancer drug delivery. (Journal of the American Chemical Society)
  9. Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system (Nature)
  10. Long-circulating and target-specific nanoparticles: theory to practice. (Pharmacological Reviews)

Their papers